CH582144A5 - - Google Patents

Info

Publication number
CH582144A5
CH582144A5 CH707473A CH707473A CH582144A5 CH 582144 A5 CH582144 A5 CH 582144A5 CH 707473 A CH707473 A CH 707473A CH 707473 A CH707473 A CH 707473A CH 582144 A5 CH582144 A5 CH 582144A5
Authority
CH
Switzerland
Application number
CH707473A
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH582144A5 publication Critical patent/CH582144A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
CH707473A 1972-05-25 1973-05-17 CH582144A5 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722226703 DE2226703A1 (de) 1972-05-25 1972-05-25 Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CH582144A5 true CH582144A5 (cs) 1976-11-30

Family

ID=5846530

Family Applications (1)

Application Number Title Priority Date Filing Date
CH707473A CH582144A5 (cs) 1972-05-25 1973-05-17

Country Status (12)

Country Link
JP (1) JPS4941367A (cs)
AT (1) AT323155B (cs)
AU (1) AU5607873A (cs)
BE (1) BE800066A (cs)
CA (1) CA1005062A (cs)
CH (1) CH582144A5 (cs)
CS (1) CS179416B2 (cs)
DD (1) DD106170A5 (cs)
DE (1) DE2226703A1 (cs)
FR (1) FR2185414B1 (cs)
GB (1) GB1436893A (cs)
NL (1) NL7307313A (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235903A (en) * 1979-08-06 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
AU2003295336A1 (en) 2002-09-19 2004-04-08 Dennis A. Carson Use of etodoclac to treat hyperplasia
ES2530972T3 (es) * 2003-09-12 2015-03-09 Elixir Pharmaceuticals Inc Métodos de tratamiento de trastornos
US20060074124A1 (en) 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
JP2007507524A (ja) 2003-10-02 2007-03-29 セフアロン・インコーポレーテツド インドール誘導体
KR20190004843A (ko) * 2008-07-23 2019-01-14 아레나 파마슈티칼스, 인크. 자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[b]인돌-3-일)아세트산 유도체
JP5726737B2 (ja) 2008-08-27 2015-06-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 自己免疫障害および免疫性障害の治療において有用なs1p1受容体のアゴニストとしての置換三環式酸誘導体
CN108558740B (zh) 2010-01-27 2021-10-19 艾尼纳制药公司 S1p1受体调节剂及其盐的制备方法
CA2789480A1 (en) 2010-03-03 2011-09-09 Arena Pharmaceuticals, Inc. Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
HUE060476T2 (hu) 2015-06-22 2023-03-28 Arena Pharm Inc (R)-2-(7-(4-ciklopentil-3-(trifluormetil)benziloxi)-1,2,3,4- tetrahidrociklopenta[B]indol-3-il)ecetsav kristályos L-arginin-sója S1P1 receptorral kapcsolatos rendellenességek esetén való alkalmazásra
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
CN110545848A (zh) 2017-02-16 2019-12-06 艾尼纳制药公司 用于治疗具有肠外表现的炎症性肠病的化合物和方法
US12156866B2 (en) 2018-06-06 2024-12-03 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
EP3847158A1 (en) 2018-09-06 2021-07-14 Arena Pharmaceuticals, Inc. Compounds useful in the treatment of autoimmune and inflammatory disorders
CN114634442B (zh) * 2022-04-02 2023-10-13 内蒙古民族大学 一种四氢咔唑酮化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586678A5 (cs) * 1970-05-25 1977-04-15 Hoffmann La Roche
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Also Published As

Publication number Publication date
FR2185414B1 (cs) 1976-08-13
GB1436893A (en) 1976-05-26
FR2185414A1 (cs) 1974-01-04
AT323155B (de) 1975-06-25
DD106170A5 (cs) 1974-06-05
AU5607873A (en) 1974-11-28
DE2226703A1 (de) 1973-12-13
CS179416B2 (en) 1977-10-31
NL7307313A (cs) 1973-11-27
JPS4941367A (cs) 1974-04-18
CA1005062A (en) 1977-02-08
BE800066A (fr) 1973-11-26

Similar Documents

Publication Publication Date Title
FR2185414B1 (cs)
JPS4927245A (cs)
JPS5318053Y2 (cs)
FR2169165B3 (cs)
JPS532339B2 (cs)
FR2171074A1 (cs)
JPS49111692U (cs)
CS160925B1 (cs)
CS161342B1 (cs)
CS154825B1 (cs)
CS154989B1 (cs)
CS155088B1 (cs)
CS157431B1 (cs)
CS157582B1 (cs)
JPS4986512U (cs)
JPS4951842U (cs)
JPS4934063U (cs)
CS158523B1 (cs)
CS158490B1 (cs)
JPS4910927U (cs)
JPS48109250U (cs)
CS154829B1 (cs)
CS161336B1 (cs)
CH582430A5 (cs)
CH584834A5 (cs)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased